The risk factors include a previous diagnosis of lung fibrosis, older age, poor performance status, male gender, smoking history, previous or concomitant ILD, comorbid pleural effusion, and coexisting heart disease.65,166 It is also the main cause of death in EGFR TKI therapy. This evidence concerns the gene EGFR and interstitial lung disease.